GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer. Dr. Teisseyre will oversee product design and development, clinical science, operations, cybersecurity, and […]
Other News
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
ARDSLEY, N.Y.–(BUSINESS WIRE)–ARMGO Pharma, Inc. (ARMGO), a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs known as Rycals®, announced today the enrollment of the first patient in a Phase 2 proof of concept clinical trial using its Rycal ARM210 (also known as S48168), for the treatment […]
Amarin Appoints Patrick Holt as President and Chief Executive Officer
DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. Aaron Berg, who served as […]
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
PRINCETON, N.J., July 19, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August […]
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the […]
Philips Foundation partners with World Heart Federation to provide half a million children at risk of rheumatic heart disease with access to life-saving early detection
AMSTERDAM, July 19, 2023 /PRNewswire/ — Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, together with World Heart Federation (WHF), today announced a ground-breaking partnership to promote awareness, medical training as well as early diagnosis and treatment of rheumatic heart […]
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
RA’ANANA, Israel, July 19, 2023 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, announced today that it has entered into a collaboration agreement with Perfusion Solution, Inc. (“Perfusion Solution”). The collaboration involves combining the INSPIRA™ ART100 product with Perfusion Solution’s broad commercial […]
Endo Launches Bivalirudin Injection in Ready-to-Use Vials
DUBLIN, July 18, 2023 /PRNewswire/ — Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial. It is the only ready-to-use liquid format of bivalirudin on the market in the U.S. “Hospital practitioners work hard to […]
Teleflex Completes Enrollment in Percutaneous Coronary Intervention Study
WAYNE, Pa., July 19, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in the prospective multicenter RingerTM PTCA study. RingerTM PTCA is one of two clinical studies evaluating the performance of the novel RingerTM Perfusion Balloon Catheter. The RingerTM PTCA […]
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30 million. The financing round was led by Revelation Partners with significant participation from the company’s existing investors, including Pacific General Ventures and EW […]



